Verona Pharma plc (VRP.L) (LON:VRP – Get Free Report)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 55 ($0.70) and traded as low as GBX 50 ($0.63). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.70), with a volume of 70,791 shares traded.
Verona Pharma plc (VRP.L) Stock Up 5.8 %
The firm’s 50-day moving average is GBX 55 and its 200 day moving average is GBX 55. The firm has a market capitalization of £228.00 million and a PE ratio of -1.68. The company has a debt-to-equity ratio of 6.85, a quick ratio of 2.47 and a current ratio of 2.99.
About Verona Pharma plc (VRP.L)
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
See Also
- Five stocks we like better than Verona Pharma plc (VRP.L)
- Why Invest in High-Yield Dividend Stocks?
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- How to Use Stock Screeners to Find Stocks
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- ETF Screener: Uses and Step-by-Step Guide
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.